WuXi Biologics CEO: Vaccine CDMO is the next area of growth

Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion

picture of

Breaking News

Pall Corporation wins supply contract with Servier

The filtration specialist will supply exclusive tech and services to Servier's new biomanufacturing site in France

Onyx Scientific eyes UK facility expansion for commercial API licence

Licence approval from the MHRA is expected this year and will see the British CRO take customers’ projects from ...

Lonza completes $15m expansion of manufacturing facility in Tampa

The plant in the US supports solid oral dose development and manufacturing, encapsulation and micro-dosing capabilities

Process optimisation with flow chemistry

WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more ...

Catalent gains access to Sanofi Active Ingredient Solutions capabilities

Agreement between the CDMOs comprises spray drying manufacturing services in the UK

Telix Pharmaceuticals finds nuclear medicine CMO in Brazil

Grupo RPH is the owner of the only private-owned fully GMP nuclear medicine production facility in Brazil

CMC strategies for the acceleration of commercial-ready ADC manufacturing

The potential for antibody-drug conjugate (ADC) programmes to accelerate from early to late stage clinical development ...

Probiotec pays $23m for Australian contract packaging company

If specific earnings hurdles are made ABS will receive a further $5m

KriGen Pharmaceuticals plans first US manufacturing site

The Indian company will manufacture medical IV bags and liquid injectables at its new $7m facility in Lillington, NC

Small molecule CDMOs reacting to changing market demands

The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...

The Manufacturing Chemist outsourcing roundtable: part II

Having talked about upcoming trends, potential growth and in-demand services in Part I, I open the second session by ...

The Manufacturing Chemist outsourcing roundtable: part I

Discussing the upcoming and ongoing trends in the contract pharmaceutical sector, Dr Kevin Robinson recently caught up ...

Catalent wins CDMO contract with Amicus Therapeutics

The US biotech company has chosen Paragon Gene Therapy development and manufacturing capability for lysosomal disorder ...

Manufacturing Chemist Live 2020: Call for papers

The inaugural Manufacturing Chemist Live is inviting industry experts to submit papers for the event to be held 2 -3 ...